TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
XCUR

Exicure Inc

Healthcare · Biotechnology

1.20$ -0.8% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow XCUR
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-511.0% -487.5% -203.6% -16,514.4% 101.6% -236.4% – -123.7% – -582.0% –
5.6% 17.4% 2.4% 303.4% 55.9% 8.7% – 6.4% – 164.8% –
15.5% 65.8% 15.0% 1,533.1% 142.0% 13.1% – 4.7% – 4.4% –
-298.1% 72.3% 12.8% 2,104.2% 115.0% 11.2% – 4.9% – – –
18.7% 1,039.5% -107.5% -9.3% 1,945.5% -110.3% – -127.7% – 126.2% –
0.5% 38.0% 9.5% 79.7% 83.5% 19.1% – 0.0% – 0.0% –
-0.5% -38.0% -9.5% -79.7% -4,894.4% 61.0% – 16.3% – – –
826.0% 46.6% 324.7% 18,679.7% 7,008.1% 20.1% – 0.0% – – –
251.3% 579.2% -10.3% 10,594.1% 964.6% 72.2% – -26.0% – 200.0% –
821.3% 611.6% 276.3% 17,021.2% 6,505.2% 91.1% – -10.8% – 2,680.4% –
309.8% 86.1% 63.2% 427.1% 1,712.3% -84.3% – -118.2% – 2,098.4% –
-511.5% -525.5% -213.1% -16,594.1% 18.1% -255.5% – -123.7% – -582.0% –

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?